Part,  Chapter, Paragraph

1   II,     5.  3.Acr|             NCP~National caner Plan~PSA~Prostate-Specific Antigen~
2   II,     5.  3.  5| geographical and temporal spread of PSA (Prostate-Specific Antigen)
3   II,     5.  3.  5|             due to the diffusion of PSA test in more affluent countries.
4   II,     5.  3.  5|         Figure 5.3.26) reflects the PSA test diffusion. Mortality
5   II,     9.  3.  1|        status should be assessed by PSA analysis and digital examination